Short Term
Mean Reversion
Neutral
Trend
Neutral
Event
Neutral
Halo Model
MQV
Very Strong
GARP
Very Strong
MQV Small
Neutral
Momentum
Price
Very Strong
Earnings
Very Strong
Growth
Earnings
Very Strong
Dividends
Very Strong
Quality
Capital Efficiency
Very Strong
Balance Sheet
Very Strong
Telephone
61.7.3219.0085
Address
Unit 4 26 Brandl Street Brisbane Technology Park Eight Mile Plains, Queensland (QLD) 4113
Description
AnteoTech Ltd. engages in the development, manufacturing, and distribution of life sciences, clinical diagnostics and bio-separations products and services. The company was founded in 1995 and is headquartered in Eight Mile Plains, Australia.
Market Cap
PE
EV/EBITDA
DIV Yield
Franking
Ex Dividend Date (est.)
52 weeks range
Low 0.01 - 0.04
Trade Value (12mth)
AU$11,761.00
1 week
0%
1 month
-46.15%
YTD
-63.16%
1 year
-70.59%
All time high
0.83
EPS 3 yr Growth
14.70%
EBITDA Margin
%
Operating Cashflow
-$7m
Free Cash Flow Return
-129.80%
ROIC
-176.80%
Interest Coverage
-271.70
Quick Ratio
3.00
Shares on Issue (Fully Dilluted)
2705m
HALO Sector
Healthcare
Next Company Report Date
02-Sep-25
Ex Dividend Date (est.)
N/A
Next Dividend Pay Date (est.)
N/A
Reporting Currency
AUD
Short Sell (% of issue)
0.00
Date | Announcements |
---|---|
01 May 25 |
Final Director's Interest Notice
×
Final Director's Interest Notice |
01 May 25 |
Notification of cessation of securities - ADO
×
Notification of cessation of securities - ADO |
30 April 25 |
Quarterly Activities/Appendix 4C Cash Flow Report
×
Quarterly Activities/Appendix 4C Cash Flow Report |
24 April 25 |
Quarterly Update Timing and Investor Webinar
×
Quarterly Update Timing and Investor Webinar |
15 April 25 |
Final Director's Interest Notice x 2
×
Final Director's Interest Notice x 2 |
15 April 25 |
Appointment of Interim CEO
×
Appointment of Interim CEO |
01 April 25 |
Appointment of Non-Executive Chair
×
Appointment of Non-Executive Chair |
31 March 25 |
Retirement of Non-Executive Directors
×
Retirement of Non-Executive Directors |
26 February 25 |
Half Yearly Report and Accounts
×
Half Yearly Report and Accounts |
26 February 25 |
Half Year Results and Operational Update Presentation
×
Half Year Results and Operational Update Presentation |
12 February 25 |
Presentation at Ausbiz Investor Connect Sessions
×
Presentation at Ausbiz Investor Connect Sessions |
12 February 25 |
Half Yearly Results Timing & Investor Update Call
×
Half Yearly Results Timing & Investor Update Call |
31 January 25 |
Initial Director's Interest Notice
×
Initial Director's Interest Notice |
28 January 25 |
Quarterly Activities/Appendix 4C Cash Flow Report
×
Quarterly Activities/Appendix 4C Cash Flow Report |
17 January 25 |
Notification of cessation of securities - ADO
×
Notification of cessation of securities - ADO |
17 January 25 |
Notification regarding unquoted securities - ADO
×
Notification regarding unquoted securities - ADO |
15 January 25 |
Appointment of Non-Executive Director
×
Appointment of Non-Executive Director |
16 December 24 |
Application for quotation of securities - ADO
×
Application for quotation of securities - ADO |
16 December 24 |
Change of Director's Interest Notice x 5
×
Change of Director's Interest Notice x 5 |
13 December 24 |
Results of Entitlement Offer
×
Results of Entitlement Offer |
13 December 24 |
Update - Proposed issue of securities - ADO
×
Update - Proposed issue of securities - ADO |
05 December 24 |
Entitlement Offer Update
×
Entitlement Offer Update |
03 December 24 |
Life Sciences Update
×
Life Sciences Update |
29 November 24 |
Notification regarding unquoted securities - ADO
×
Notification regarding unquoted securities - ADO |
29 November 24 |
Change of Director's Interest Notice x 1
×
Change of Director's Interest Notice x 1 |
Load More
Load Less
Percent of Issue
Value ($M)
Prior Change
7 Day Change
1 Month Change
3 Month Change
Access data on short interest, stock performance, and potential short-selling candidates across various markets to make informed decisions and optimize your trading strategies.
Unlock true investor intelligence
Research, trade and manage global markets from one place with HALO Global. It’s trading - the way you want it.
Get the latest insights and hot tips delivered right to your inbox
HALO Technologies Pty Ltd ABN 54 623 830 866 is a Corporate Authorised Representative No 1261916 of Macrovue Pty Ltd ABN 98 600 022 679 AFSL 484264. Macrovue Pty Ltd is a wholly owned subsidiary of HALO Technologies Pty Ltd.